[Cognitive impairments and breast cancer: a critical review of the literature].

Abstract:

:Since the 1980's, women treated for breast cancer are reporting moderate cognitive impairments during and after chemotherapy. These cognitive impairments may be related to chemotherapy but also to hormone therapy, psychological distress, fatigue... This work is a critical review of the literature, which reports types of impairments, frequency, severity, causes and mechanisms involved in this issue. It also provides an update on potential moderators factors, which may be associated with mild cognitive impairments and various tools for their assessment used in the studies. These studies--selected between 1997 and 2008--show that cognitive impairments are frequently reported by patients with breast cancer but that the mechanisms are still poorly understood and that the methods of assessment are very heterogeneous and difficult to compare. This review indicates that future studies should include more homogenous patient groups, be longitudinal, use more sensitive and specific assessment tools and control moderators factors that play a role in impairment in cognitive function.

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Vandenbossche S,Fery P,Razavi D

doi

10.1684/bdc.2008.0818

subject

Has Abstract

pub_date

2009-02-01 00:00:00

pages

239-48

issue

2

eissn

0007-4551

issn

1769-6917

pii

bdc.2008.0818

journal_volume

96

pub_type

杂志文章,评审
  • [Renovascular effects of antiangiogenic drugs].

    abstract::During the last decade, inhibitors of the vascular endothelial growth factor (VEGF) were developed for the treatment of cancer. Many anti-VEGF are available but the issue is still the same: to inhibit the effect of the VEGF on their receptors. There are two main classes, depending on the mechanism of action by blockin...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2016.05.005

    authors: Deray G,Janus N,Aloy B,Launay-Vacher V

    更新日期:2016-07-01 00:00:00

  • [Patients on oral anticancer drugs and coordinated pathway: CHIMORAL, feedback from care providers].

    abstract:INTRODUCTION:Oral anticancer drugs have raised the question of how to follow-up these patients and how to coordinate this follow-up. The CHIMORAL study evaluated the involvement of primary care providers and a coordination by territorial health networks. Training/information tools were provided, as well as weekly nursi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2020.08.014

    authors: Maritaz C,Napoly L,Burnel S,Lotz JP

    更新日期:2020-12-01 00:00:00

  • [The sentinel lymph node in carcinomas of the digestive tract].

    abstract::Localization of the sentinel lymph node (SLN) in digestive cancers was performed mainly for colorectal primaries and less frequently for oeso-gastric primaries. This technique is feasible in vivo or ex vivo, with a vital dye and/or with a radiolabeled marker. Technically, detection reliability is good, provided a few ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Elias D,Lasser P,Duvillard P

    更新日期:2002-06-01 00:00:00

  • [Frequency of cancer in France: 2004 update].

    abstract::The most recent cancer mortality and morbidity data available for France are presented. In 1999, cancers are the first cause of death among men (87,000 deaths) and the second most common among women (57,000 deaths) after cardiovascular diseases. Lung cancer is the most common cause of cancer death (21,000) in the male...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Hill C,Doyon F

    更新日期:2004-01-01 00:00:00

  • [Technical considerations for KRAS testing in colorectal cancer. The biologist's point of view].

    abstract::Targeted therapy against the EGF receptor was shown to be effective in a subgroup of patients with KRAS wild-type colorectal cancer. Therefore, cetuximab (Erbitux) or panitumumab (Vectibix) obtained the authorization by the EMEA restricted to patients with KRAS wild-type tumours. KRAS mutational testing has become par...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2009.0996

    authors: Blons H,Laurent-Puig P

    更新日期:2009-12-01 00:00:00

  • [Opioid switch and change of route of administration in cancer patients treated by morphine].

    abstract::This paper reviewed the 2002 guidelines established by the National Federation of Cancer Centres. A group of experts nominated by the 3 French Societies involved in the treatment of cancer pain (AFSOS, SFAP, SFETD), established new guidelines ratios for morphine switching and/or changing of route of administration, in...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,实务指引,评审

    doi:10.1016/j.bulcan.2018.06.011

    authors: Michenot N,Rostaing S,Baron L,Faure S,Jovenin N,Hubault P,Delorme T,Collin E,Filbet M,Chvetzoff G,Delorme C,Minello C,Magnet M,Ammar D,Krakowski I,Poulain P

    更新日期:2018-11-01 00:00:00

  • [Treatment of peritoneal carcinomatosis with surgery and hyperthermic peroperative intraperitoneal chemotherapy (HIPEC): new aspects and validated indications].

    abstract::Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) is now an entire part of treatment of peritoneal dissemination of colorectal malignancy, and it's possible to hope prolonged survival. This treatment is more and more codified. Four indications are recognized by some tree national evaluation committees: ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2008.0553

    authors: Eveno C,Dagois S,Guillot E,Gornet JM,Pocard M

    更新日期:2008-01-01 00:00:00

  • [Imatinib in the treatment of chronic myeloid leukemia in Morocco].

    abstract:INTRODUCTION:The treatment of chronic myeloid leukemia (CML) has been revolutionized by the advent of tyrosine kinase inhibitors. The results of the IRIS trial demonstrated the efficacy and long-term safety profile of Imatinib. The objective of our work is to report the results at 15 years of treatment of CML in chroni...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2020.05.013

    authors: Dakkoune M,Qachouh M,Zoukal S,Hassoune S,Khoubila N,Cherkaoui S,Lamchahab M,Rachid M,Madani A,Quessar A

    更新日期:2020-09-01 00:00:00

  • [ALL in adult patients: Contribution and limits of pediatric management].

    abstract::For two decades, the prognostic of adult patients with ALL was improved based on pediatric-inspired protocols. These approaches based on less myelosuppressive drugs have led to improved response rates, decreased relapse rates, with a benefit in survival observed in patients aged up to 50-60-years-old. Therapeutic inte...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2020.07.008

    authors: Rabian F,Boissel N

    更新日期:2020-09-24 00:00:00

  • [Hospital teaching of oncology].

    abstract::Theoretical teaching of oncology was improved, 15 years ago, by individualizing a special university course during medical studies in France. However medical students need also practical exercising by relation with cancer patients. The main goals may be defined and given to students at the beginning of practical cours...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Hoerni B,Vrousos C

    更新日期:1985-01-01 00:00:00

  • [Primary non-Hodgkin's high grade malignant lymphoma of the digestive system. A prospective study of the combination of surgery-chemotherapy-radiotherapy].

    abstract::We report a prospective study concerning the association of surgery-chemotherapy and radiotherapy in the treatment of primary high grade digestive non-Hodgkin's lymphomas in 19 patients. The analysis of 11 stages IE, 5 stages II1E and 3 stages II2E allowed us to evaluate the efficacy and the tolerance of this triple t...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Renou P,Colombat P,Fetissof F,Calais G,Metman EH,Combe M,Dugay J,Martin JF,Linassier C,Lamagnere JP

    更新日期:1990-01-01 00:00:00

  • [Experimental program personalized care in patients with head and neck cancer].

    abstract:OBJECTIVE:Describe the implementation and preliminary results of the “Experimental Program Personalized care” in patients with Head and Neck cancer. MATERIALS AND METHODS:After being selected a graduate nurse status, called coordination, participated in the development of forms of detection needs and concerns of patie...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2014.2040

    authors: Hans S,Scotte F,Hoffman C,Pelicier N,Ménard M,Badoual C,Oudard S,Housset M,Brasnu D

    更新日期:2014-10-01 00:00:00

  • [Role of high-dose chemotherapy with hemopoietic stem-cell support in the treatment of adult patients with high-grade glioma].

    abstract::Despite surgery, post-operative irradiation and adjuvant conventional chemotherapy, prognosis of high-grade gliomas remains poor. Carmustine (BCNU) has been shown to have limited activity at conventional dosage but is still the standard chemotherapy. Activity of chemotherapy is limited by the blood-brain barrier imper...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Linassier C,Destrieux C,Benboubker L,Alcaraz L,Bergemer-Fouquet AM,Jan M,Calais G,Colombat P

    更新日期:2001-09-01 00:00:00

  • [Thyroid carcinoma on struma ovarii: Diagnosis and treatment].

    abstract::Thyroid carcinoma on struma ovarii (TCSO) is a rare ovarian tumour, derivate from monodermic teratomas. It represents about 0.01% of overall ovarian tumours and 5 to 10% of struma ovarii. The diagnosis is histologic and retrospective after pelvic surgery; radiographic imaging being unspecific. Because of its rarity, t...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2017.11.014

    authors: Lebreton C,Al Ghuzlan A,Floquet A,Kind M,Leboulleux S,Godbert Y

    更新日期:2018-03-01 00:00:00

  • [Expectations of patients with ovarian cancer. Results of the European investigation EXPRESSION III in French patients from GINECO group].

    abstract::EXPRESSION III was designed to evaluate the information, needs and expectations of patients with ovarian cancer in different European countries. This abstract focuses on specific results from French OC patients. Two hundred and fifty-seven patients filled a 27-item questionnaire during a medical visit. Median age rang...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2014.09.004

    authors: De Cock L,Kieffer A,Kurtz JE,Joly F,Weber B

    更新日期:2015-03-01 00:00:00

  • [Cell cycle regulation after exposure to ionizing radiation].

    abstract::When cells are exposed to ionizing radiation, they initiate a complex response that includes the arrest of cell cycle progression in G1 and G2, apoptosis and DNA repair. DNA is an important subcellular target of ionizing radiation, but oxydative damage to plasma membrane lipids initiates signal transduction pathways t...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Teyssier F,Bay JO,Dionet C,Verrelle P

    更新日期:1999-04-01 00:00:00

  • [Docetaxel and gastric cancer].

    abstract::There are very few active drugs in the treatment of metastatic gastric carcinoma. Among new drugs, docetaxel has shown one of the most important activity. With precise evaluation of objective response, this drug has demonstrated a 20% response rate in monotherapy. The favorable toxicity profile of this compound allowe...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Ducreux M,Boige V,Roth A

    更新日期:2004-03-01 00:00:00

  • [Treatment of metastatic kidney neoplasms with a new interleukin 2 protocol: The experience of the Gustave-Roussy Institute].

    abstract::Treatment of metastatic renal cell carcinoma with interleukin 2 (IL2) remains controversial despite the authorization from the French government for IL2 with the West schedule in this disease. We report herein the study of the Institute Gustave-Roussy of 73 patients, who received from 1989 to 1991 a new schedule of hi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Escudier B,Farace F,Théodore C,Angevin E,Court B,Couanet D,Dietrich PY,Culine S,Pallardy M,Hercend T

    更新日期:1995-04-01 00:00:00

  • [Chemotherapeutic intensification in germ cell tumors].

    abstract::Chemotherapy has dramatically improved the prognosis of non-seminomatous germ cell tumors (NSGCT). However, some patients relapse and others are refractory to first line chemotherapy. We studied a salvage chemotherapeutic regimen with etoposide 75 gm/m2/day, and cisplatin 40 mg/m2/day, days 1-5 and Ifosfamide 3 g/m2/d...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Droz JP,Pico JL,Ghosn M,Ostronoff M,Azab M,Theodore C,Hayat M

    更新日期:1990-01-01 00:00:00

  • [Epidemiology of HIV-associated malignancies].

    abstract::Human immunodeficiency virus (HIV)-associated malignancies include acquired immunodeficiency virus: Aids-defining malignancies, Kaposi's sarcoma, (KS), non-Hodgkin's lymphoma (NHL), and, since 1993, invasive cervical cancer (1CC), and non-Aids defining malignancies. Most cancers that are associated with HIV infection ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Launay O,Guillevin L

    更新日期:2003-05-01 00:00:00

  • [Intraoral minor salivary gland tumors. Report of 296 cases (author's transl)].

    abstract::296 intraoral minor salivary gland tumors were observed among 702 salivary tumors. The study emphasizes a frequent palatine location, observed in more than 50 per cent of theses tumors. Pleiomorphic adenomas (or so called mixed tumors), are frequently encountered; but it is noteworthy that the proportion of muco-epide...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Brocheriou C,Crepy C,Guilbert F,Lartigau G,Payen J,Recoing J

    更新日期:1980-01-01 00:00:00

  • [Pharmacological consequences of the targeting of epidermal growth factor receptor].

    abstract::Through clearly identified molecular mechanisms, EGFR targeting leads to cell physiology modifications as cell proliferation, apoptosis and DNA repair. These mechanisms can explain the proper activity of EGFR targeting drugs but also represent a strong rational basis on which several experimental studies have been des...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Milano G,Magné N

    更新日期:2003-11-01 00:00:00

  • [New challenge in head and neck oncology surgery: the transoral robotic surgery].

    abstract::Robotic assisted surgery is a new field of developing program for many specialties. As to head and neck oncology, the new procedure potentially offers alternatives to conventional surgery with decreased morbidity. The aim of this article is a description of the state of the art via a review of the literature. We empha...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2009.1022

    authors: Mallet Y,Moriniere S,Ceruse P,El Bedoui S

    更新日期:2010-01-01 00:00:00

  • [Angiopoietin-2, a new molecular actor involved in vascular tree morphogenesis].

    abstract::Angiopoietin-2 is a new member of the family of the ligands of Tek (Tie2), a transmembrane receptor with tyrosine kinase activity which is specifically expressed in endothelial cells during angiogenesis. Several lines of evidence indicate that angiopoietin-1 is involved in pericyte recruitment by endothelial cells and...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Vandenbunder B

    更新日期:1997-11-01 00:00:00

  • [Prevalence of cancer, health care and daily life assistance in people aged 75 or over living in the Tarn area (France)].

    abstract::The association between cancer and dependence was estimated using a cross-sectional study among persons 75 years of age or-older in Tarn county (area with a cancer registry recognized by the National Committee of Registries). A representative random sample stratified on age, sex, and size of district, was drawn using ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Faliu B,Berthier F,Grosclaude P,Aptel I,Cayla F,Machelard-Roumagnac M,Duchene Y

    更新日期:1997-02-01 00:00:00

  • [Primary cerebral non-Hodgkin lymphoma in non-immunocompromised subjects].

    abstract::Cerebral non Hodgkin's lymphomas (NHL) of immunocompetent patients are rare disease (1% of all NHL), but their incidence has been steadily increasing in the last 20 years. Most cerebral NHL are diffuse large cell NHL with a B phenotype. These tumors are most often localized in the central nervous system, the eye or me...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,meta分析

    doi:

    authors: Blay JY

    更新日期:1997-10-01 00:00:00

  • [Nice-Saint-Paul de Vence 2020 recommendations for clinical practice: Management of metastatic and/or relapsing endometrial cancer].

    abstract::Endometrial cancer is a common cancer in older women and is often associated with comorbidities. Management of metastatic disease and/or relapse requires a multidisciplinary approach. Recent advances in the understanding of oncogenesis and molecular classification of endometrial cancers offer new therapeutic perspecti...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,实务指引

    doi:10.1016/j.bulcan.2020.06.006

    authors: Alexandre J,Le Frere-Belda MA,Prulhiere K,Treilleux I,Leary A,Pomel C,Chargari C,Ducassou A,Joly F,groupe ARCAGY-GINECO.

    更新日期:2020-10-01 00:00:00

  • [PI3 kinases and the control of autophagia].

    abstract::Macroautophagy or autophagy is a degradative pathway terminating in the lysosomal compartment after the formation of a cytoplasmic vacuole that engulfs macromolecules and organelles. The recent discovery of the molecular controls of autophagy that are common to eukaryotic cells from yeast to human suggests that the ro...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Meley D,Pattingre S,Codogno P

    更新日期:2006-05-01 00:00:00

  • [Haploidentical hematopoietic stem cell transplantation: Guidelines from the Francophone society of marrow transplantation and cellular therapy (SFGM-TC)].

    abstract::Haploidentical hematopoietic stem cell transplantation (HSCT) is being increasingly used due to improvement of the transplantation procedures allowing a reduction of graft-versus-host-disease (GVHD) and of transplant-related mortality (TRM). Such improvements have been particularly observed after administration of T-r...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,实务指引,评审

    doi:10.1016/j.bulcan.2016.09.007

    authors: Nguyen S,Chalandon Y,Lemarie C,Simon S,Masson D,Dhedin N,Suarez F,Renaud B,Charbonnier A,Yafour N,François S,Duléry R,Blaise D,Yakoub-Agha I,Rubio MT

    更新日期:2016-11-01 00:00:00

  • [Propensity score: interest and limits].

    abstract::Propensity score, an indicator of the propensity to get one treatment among two (or more), is encountered in non randomized studies (prospective or retrospective). It is calculated after the research of predictive factors for treatment attribution, and corresponds to the probability to receive one of the treatments co...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Kwiatkowski F,Slim K,Verrelle P,Chamorey E,Kramar A

    更新日期:2007-07-01 00:00:00